- Home
- BATRA vs XENE Comparison
BATRA vs XENE Comparison
Compare BATRA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATRA
- XENE
- Stock Information
- Founded
- BATRA 1991
- XENE 1996
- Country
- BATRA United States
- XENE Canada
- Employees
- BATRA N/A
- XENE N/A
- Industry
- BATRA Broadcasting
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- BATRA Industrials
- XENE Health Care
- Exchange
- BATRA Nasdaq
- XENE Nasdaq
- Market Cap
- BATRA 2.6B
- XENE 2.3B
- IPO Year
- BATRA N/A
- XENE 2014
- Fundamental
- Price
- BATRA $49.07
- XENE $32.05
- Analyst Decision
- BATRA Strong Buy
- XENE Strong Buy
- Analyst Count
- BATRA 2
- XENE 11
- Target Price
- BATRA $56.50
- XENE $54.82
- AVG Volume (30 Days)
- BATRA 55.8K
- XENE 977.8K
- Earning Date
- BATRA 08-07-2025
- XENE 08-07-2025
- Dividend Yield
- BATRA N/A
- XENE N/A
- EPS Growth
- BATRA N/A
- XENE N/A
- EPS
- BATRA N/A
- XENE N/A
- Revenue
- BATRA $672,879,000.00
- XENE $7,500,000.00
- Revenue This Year
- BATRA $8.81
- XENE N/A
- Revenue Next Year
- BATRA $5.01
- XENE $253.71
- P/E Ratio
- BATRA N/A
- XENE N/A
- Revenue Growth
- BATRA 4.04
- XENE N/A
- 52 Week Low
- BATRA $38.67
- XENE $26.74
- 52 Week High
- BATRA $49.47
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- BATRA 79.66
- XENE 51.34
- Support Level
- BATRA $45.06
- XENE $31.22
- Resistance Level
- BATRA $45.82
- XENE $33.46
- Average True Range (ATR)
- BATRA 0.93
- XENE 1.28
- MACD
- BATRA 0.39
- XENE 0.27
- Stochastic Oscillator
- BATRA 93.99
- XENE 68.60
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.